{"name":"Abbott Products","slug":"abbott-products","ticker":"","exchange":"","domain":"","description":"Abbott Products is a pharmaceutical company with a focus on developing innovative treatments in various therapeutic areas. The company has a pipeline of drugs in different stages of development, including SLV342 and SLV337.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxNdjBLcEVxLW1QTVhsd2dtcVA3bWZMTUxDZjh3Y2FvUnJOSXFEa21TSEc3MHRQa0paN0ZzV3A1X045TUdqeGxfczk1VGwzVUNycWQ2SFZ1S0FIb09pcnBCSzl0b3AwaTNLc1NoZ3dMLVZEdVpWdGhfWlhLQUxqU1dhUEJhTFhXRmpUbVNBZ0RDNno0WlliWUJrMUxON2Zhb3Nqdlc5YS1uS0NDRDRLY0hUWGllTWxMNG1XVGUtQ1E4MzBHV214dkE?oc=5","date":"2026-04-08","type":"pipeline","source":"AD HOC NEWS","summary":"Abbott India Ltd stock: Why it's a steady pick in India's pharma boom - AD HOC NEWS","headline":"Abbott India Ltd stock: Why it's a steady pick in India's pharma boom","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTE1WeFFRUXVTd0VBY1VIa255UUpoUVYxckl2MFFKYkF1R1JKcElJRTI5N2phYUQxODhSRWx2a3JEcnZlSmpMbjlBdFhhUndnS0wzU2U0R19HVnhWYnBWVlhSRmY0dGpCVzdqSWZJMUdnYWN4STd5enJ3QVpn?oc=5","date":"2026-03-11","type":"earnings","source":"Statista","summary":"Abbott Laboratories' segment revenues from 2017 to 2025 - Statista","headline":"Abbott Laboratories' segment revenues from 2017 to 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE4xU0NhaGl0a2ZPUHIxQVF2Tk1CSTdmRGtZRkJzeExyTExGRUF3bncxQnRDY0JOcElNZzNDbThUV0MzZUpnUDhZUW5ub0ctQXNtR2lJNl9vUEROTFJuWXpmS05QU0tBZWsyX0hvaEpXTmJqeXl1MUlvV3luV3E?oc=5","date":"2026-03-11","type":"earnings","source":"Statista","summary":"Abbott Laboratories revenue 2004-2025 - Statista","headline":"Abbott Laboratories revenue 2004-2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxNZU5DOThHR1NQR1NjWlVxZU0xd2xyOExYMWN4eVA2WXFLbnFpTWNodVhQZ0UxaVlyVi1HTWo0REpFb2pNNGFTU0dTeFJha0VQSmQteEd4UXAtWlMxRmJlakNlWVphc0pDWW9qTktzbFlySm9wTENQdlczWGNJWDNzRDlJd3l4S0NJbFF1cGFUcVVSSXhtd2MwNDRRVFBKakdweUNGODhfVVB6OHpUXzBIbjg1bzRJQ1k3T0NyajdXTmZkaGF2MFVYaHY1SXhrUQ?oc=5","date":"2026-03-04","type":"regulatory","source":"Reuters","summary":"Abbott set to face trial over claims premature infant formula caused deadly disease - Reuters","headline":"Abbott set to face trial over claims premature infant formula caused deadly disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE8xTm5zT3hiNnUtZHd0dUxkLTdmSWFwYVA2Z2VUcjdjbXQtNFBjN0ZwaEJWeW10VU9lTmFxbmJBQXlja0h0anNyMVlBQUotZEY2QUk1MVVhZUVILXpRQ0VjSzhDUnl1dVRqWVRYN2V2OHhnZjhBZGE3bQ?oc=5","date":"2026-02-16","type":"pipeline","source":"Reliable Plant","summary":"Abbott completes $6.2 billion acquisition of Solvay Pharmaceuticals - Reliable Plant","headline":"Abbott completes $6.2 billion acquisition of Solvay Pharmaceuticals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxOX1pBN09FRHAzM0xpV3NkQWliVHp1TEJ3cnBnMU0teUoza21tTUVNMlBPeDZnTV9DUzNZTGdLYmZCRUJwc2kwX0pFbFQ0MEUwTGZteGZKdVZFQXcxcnFiWVFlVlpsWGV3cnRUVHpZMm5vRmpYSjN5VWFTOEFVLTJyMm83LWpkUGdxLW1RbG1CRTJ2SVRCLUhN?oc=5","date":"2026-01-22","type":"earnings","source":"Investor's Business Daily","summary":"Abbott Tumbles On Disappointing Fourth Quarter As Exact Closing Looms - Investor's Business Daily","headline":"Abbott Tumbles On Disappointing Fourth Quarter As Exact Closing Looms - Investor's Business Daily","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTE1UMmJNTkZRZ3lUeHgwUWRpcFNzdElSUTFVcVJjQTUyOWRYdnNMWk14bFBUTVlpWDExN01aWUFfbXBvTFdwRU5uNEVFclJSby1PY1RaSjYyUDBjOHpqOWpaSlJR?oc=5","date":"2025-12-04","type":"pipeline","source":"The Pharma Letter","summary":"Abbott - The Pharma Letter","headline":"Abbott","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxNeGJHZG5nN2xjNS1aU3RRUDc4LXVadnU2bGNTQ2pFeGFOOVpRN1NOdVB4THhtSVM2VUh4cEk1U045RE1TNmN5UUh5ZTlCSGVqNERHNEVXanRYTE5rUkRvQUJpamFaS1FYaGhMRkV2bkt1Nkt6d0l0YTFhdG1LLXRxbEExeGZYRTZ3N1RvczF4dkVKS19K?oc=5","date":"2025-11-21","type":"pipeline","source":"Yahoo Finance","summary":"AbbVie, Biogen, BioMarin Pharmaceutical, DexCom, and Abbott Laboratories Stocks Trade Up, What You Need To Know - Yahoo Finance","headline":"AbbVie, Biogen, BioMarin Pharmaceutical, DexCom, and Abbott Laboratories Stocks Trade Up, What You Need To Know","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxQMXJsdUJWbEFXYlNxTWhMU1NVQnZHY1lvdVBrY083cmladU1adHJvczl5a3NhQUJzRU9NcjNZM2psY05kR1lhTWpKbkRZa2pDSHpfU3ZJcHJBbWloSEpRUUhvZE56OW55amx2bzF5eFIxNzk4LUpJZV9aZERySGpWS1pwU2VyMzlfbmNnU096T1pSSXNva3dtQVREcGRINHg3SExMZg?oc=5","date":"2025-10-16","type":"pipeline","source":"Modern Healthcare","summary":"Abbott cuts top end of 2025 guidance as tariff threat looms - Modern Healthcare","headline":"Abbott cuts top end of 2025 guidance as tariff threat looms","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxQeFo1aUR5bllXOW9Ccm5jY3lZaFVWWGEwSVBWWGRDZlBKcVJ2MzVielU3LVJSc0NpaEp2V2hRZTYzemZBMl9tbFJvS2YzQkFDZVNhenNNYkI3elZEcjZEUkhjTHZ4cV9uTmM4LWk2ajdjSDg3d2JlVkkzOGMtR0pFZ25uVERDWFV3SmlLQmZ3ZzVKV3pIV1NBbEpPeG45WTkxMk9FdVRwUWtRek1XVUIybG5aNVNNR2dyajlyanBkSWwyTHc?oc=5","date":"2025-09-15","type":"pipeline","source":"Fierce Pharma","summary":"Abbott spreads holiday cheer, heart health awareness in upcoming Hallmark movie - Fierce Pharma","headline":"Abbott spreads holiday cheer, heart health awareness in upcoming Hallmark movie","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPQVVld2pwbGg0N29kdHJ5TmJlYy1DelBQYi1hR245czY4Y2V1MF9SeUtPazRKS1JrM2tVM2JDRDktZ3JBUTgtNXM1TXVPb1NZTjhJZnFyT3Z5RWJwYm1TbGdNdFN6d2xXaU5hWGVQakRmQlBnaFpYX3RJWEtKdlN0TEl2b0NaQkhNUjdnNmxSSWRONnU3VmozejlRaTbSAaIBQVVfeXFMT25wZW83aVhnNkFlMzlwMmltaGNHeHNGM1RmTFhOLWN6ejZvMFgxcHU4cDVKMDQ4dG9RMklLaDE2OTdWaXdrNXF2aktKVnRPNUhNR0g1b2FxMTYwZE9Ea1hHdDkwaFdDQU1ValdRdDk2UWJLdlRtUEJYOXFVUzN3YjFnaDd4N2VVVUxmZ1p4VUdjdHZrMVgtQWdsYThsRlN1c0hB?oc=5","date":"2025-07-17","type":"earnings","source":"CNBC","summary":"Abbott Laboratories CEO calls post-earnings stock decline 'a little bit of an overreaction' - CNBC","headline":"Abbott Laboratories CEO calls post-earnings stock decline 'a little bit of an overreaction'","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxOOGxKanNCdG5ubWZNYzlGMGIxRFd6M0NsYzNfTFBwbjg3bzdEekxwY0xSeEExV3hEb1RCUWNHeXNrYVFLZ2RJMy03UnFrUlVtdnpoMTZ4WGx6eTY5Z1E4djU2ZUdhYnFMdWYtSE1acHVST2ZDaUxCb0s2N3A3bnNiYjJfRQ?oc=5","date":"2025-06-30","type":"pipeline","source":"Seeking Alpha","summary":"Abbott Laboratories: Proactive, Adaptive, Solid (NYSE:ABT) - Seeking Alpha","headline":"Abbott Laboratories: Proactive, Adaptive, Solid (NYSE:ABT)","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}